Avion Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25K Buy
203
+12
+6% +$1.58K ﹤0.01% 347
2026
Q1
$26K Buy
191
+20
+12% +$2.8K 0.01% 288
2025
Q4
$20K Sell
171
-3
-2% -$365 ﹤0.01% 344
2025
Q3
$19K Sell
174
-6
-3% -$682 ﹤0.01% 345
2025
Q2
$19K Buy
180
+58
+48% +$6.17K ﹤0.01% 326
2025
Q1
$11K Hold
122
﹤0.01% 375
2024
Q4
$11K Buy
122
+28
+30% +$2.52K ﹤0.01% 375
2024
Q3
$7K Buy
94
+59
+169% +$4.5K ﹤0.01% 444
2024
Q2
$2K Buy
35
+18
+106% +$1.2K ﹤0.01% 614
2024
Q1
$2K Sell
17
-68
-80% -$5.23K ﹤0.01% 683
2023
Q4
$7K Buy
85
+4
+5% +$311 ﹤0.01% 329
2023
Q3
$6K Sell
81
-159
-66% -$12.2K ﹤0.01% 332
2023
Q2
$18K Buy
240
+21
+10% +$1.68K ﹤0.01% 240
2023
Q1
$18K Buy
219
+16
+8% +$1.32K ﹤0.01% 219
2022
Q4
$12K Hold
203
﹤0.01% 248
2022
Q3
$13K Hold
203
﹤0.01% 245
2022
Q2
$13K Hold
203
﹤0.01% 240
2022
Q1
$12K Hold
203
﹤0.01% 215
2021
Q4
$15K Hold
203
﹤0.01% 199
2021
Q3
$14K Buy
203
+200
+6,667% +$14.1K ﹤0.01% 209
2021
Q2
$0 Buy
+3
New +$200 ﹤0.01% 388

Other funds holding GILD

Avion Wealth's GILD Position: Q2 2026 in Review

Avion Wealth increased its Gilead Sciences (GILD) stake by 6.3% in Q2 2026, buying an estimated $1.58K and bringing the position to 203 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Avion Wealth first reported a position in GILD in Q2 2021 and has held it in 21 quarters since. The position peaked at $26K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avion Wealth held 203 shares of Gilead Sciences worth $25K as of Q2 2026.
  • Avion Wealth bought 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
  • Gilead Sciences made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #347 holding.
  • Avion Wealth first reported a position in Gilead Sciences in Q2 2021 and has held it in 21 quarters since.
  • Avion Wealth's Gilead Sciences position peaked at $26K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.